SCHEMBL10104467

SCHEMBL10104467

CCCC(OC)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28057052 0.84 CA2 (0.39)
SCHEMBL8462298 0.80
SCHEMBL6843198 0.79 CA1 (0.30)
SCHEMBL16081350 0.79 CA1 (0.30)
SCHEMBL17793660 0.79
SCHEMBL11911971 0.77
SCHEMBL12220181 0.77
SCHEMBL15966007 0.77
SCHEMBL8964563 0.76
SCHEMBL7259789 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113603568-A Preparation method of cannabidiol 厦门朝阳生物工程有限公司 2021-11-05 CN claimed
US-20230295131-A1 INHIBITORS OF RHO-ASSOCIATED COILED-COIL KINASE ANGION BIOMEDICA CORP. 2023-09-21 US disclosed
CN-109790146-B Pharmaceutical compounds 阿尔麦克探索有限公司 2022-08-23 CN disclosed
CN-111201225-B Coumarin-like ring compound as MEK inhibitor and application thereof 基石药业 2021-11-05 CN disclosed
CN-111233684-A Preparation of solid forms of gadobenate dimeglumine 伯拉考成像股份公司 2020-06-05 CN disclosed
US-8946231-B2 P2X3, receptor antagonists for treatment of pain MERCK SHARP & DOHME CORP. (US) 2015-02-03 US disclosed
US-20120021074-A1 P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN MERCK SHARP & DOHME CORP. (US) 2012-01-26 US disclosed